Company · Montreal, Quebec, Canada
Sorres Pharma Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 44
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 32
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ALENDRONATEStatus since Jun 2014 | 02302004 | Cancelled Post Market | |
| AMIODARONEStatus since Jun 2014 | 02300893 | Cancelled Post Market | |
| ASA 80Status since Jun 2014 | 02321750 | Cancelled Post Market | |
| ASA EC 80Status since Jun 2014 | 02321769 | Cancelled Post Market | |
| BICALUTAMIDEStatus since Jun 2014 | 02325233 | Cancelled Post Market | |
| BISOPROLOLStatus since Jun 2014 | 02321556 | Cancelled Post Market | |
| BISOPROLOLStatus since Jun 2014 | 02321572 | Cancelled Post Market | |
| CAPTOPRILStatus since Jun 2014 | 02242788 | Cancelled Post Market | |
| CAPTOPRILStatus since Jun 2014 | 02242789 | Cancelled Post Market | |
| CAPTOPRILStatus since Jun 2014 | 02242790 | Cancelled Post Market | |
| CAPTOPRILStatus since Jun 2014 | 02242791 | Cancelled Post Market | |
| CHOLESTYRAMINEStatus since Oct 2010 | 02236969 | Cancelled Post Market | |
| CHOLESTYRAMINEStatus since Oct 2010 | 02236970 | Cancelled Post Market | |
| CYCLOBENZAPRINEStatus since Jun 2014 | 02325195 | Cancelled Post Market | |
| FLUCONAZOLEStatus since Jun 2014 | 02301938 | Cancelled Post Market | |
| FLUCONAZOLEStatus since Jun 2014 | 02301946 | Cancelled Post Market | |
| FLUCONAZOLEStatus since Jun 2014 | 02301954 | Cancelled Post Market | |
| GABAPENTINStatus since Jun 2014 | 02304775 | Cancelled Post Market | |
| GABAPENTINStatus since Jun 2014 | 02304783 | Cancelled Post Market | |
| GABAPENTINStatus since Jun 2014 | 02304791 | Cancelled Post Market | |
| HYDROMORPHONEStatus since Jun 2014 | 02192101 | Cancelled Post Market | |
| HYDROMORPHONEStatus since Jun 2014 | 02192144 | Cancelled Post Market | |
| HYDROMORPHONEStatus since Jun 2014 | 02249928 | Cancelled Post Market | |
| HYDROMORPHONEStatus since Jun 2014 | 02249936 | Cancelled Post Market | |
| LISINOPRILStatus since Jun 2014 | 02321580 | Cancelled Post Market | |
| LISINOPRILStatus since Jun 2014 | 02321610 | Cancelled Post Market | |
| LISINOPRILStatus since Jun 2014 | 02321629 | Cancelled Post Market | |
| METFORMINStatus since Jun 2014 | 02242793 | Cancelled Post Market | |
| METOPROLOL-LStatus since Jun 2014 | 02315106 | Cancelled Post Market | |
| METOPROLOL-LStatus since Jun 2014 | 02315114 | Cancelled Post Market | |
| METOPROLOL-LStatus since Jun 2014 | 02315122 | Cancelled Post Market | |
| PANTOPRAZOLEStatus since Jun 2014 | 02310201 | Cancelled Post Market | |
| PAROXETINEStatus since Jun 2014 | 02302012 | Cancelled Post Market | |
| PAROXETINEStatus since Jun 2014 | 02302020 | Cancelled Post Market | |
| PAROXETINEStatus since Jun 2014 | 02302039 | Cancelled Post Market | |
| PRAVASTATINStatus since Jun 2014 | 02301792 | Cancelled Post Market | |
| PRAVASTATINStatus since Jun 2014 | 02301806 | Cancelled Post Market | |
| PRAVASTATINStatus since Jun 2014 | 02301814 | Cancelled Post Market | |
| RANITIDINEStatus since Jun 2014 | 02303353 | Cancelled Post Market | |
| RANITIDINEStatus since Jun 2014 | 02303388 | Cancelled Post Market | |
| SOTALOLStatus since Jun 2014 | 02325209 | Cancelled Post Market | |
| SOTALOLStatus since Jun 2014 | 02325217 | Cancelled Post Market | |
| VALACYCLOVIRStatus since Jun 2014 | 02320916 | Cancelled Pre Market | |
| VERAPAMIL SRStatus since Jun 2014 | 02303558 | Cancelled Post Market |
Notices of Compliance
Newest first.
- PANTOPRAZOLEJanuary 20, 2014 · NOC 15143 · Supplement to an Abbreviated New Drug Submission (SANDS)
- RABEPRAZOLE ECSeptember 15, 2011 · NOC 12642 · Abbreviated New Drug Submission (ANDS)
- PAROXETINEJune 14, 2011 · NOC 12427 · Abbreviated New Drug Submission (ANDS)
- GABAPENTINFebruary 7, 2011 · NOC 12047 · Abbreviated New Drug Submission (ANDS)
- OMEPRAZOLEJanuary 14, 2011 · NOC 12000 · Abbreviated New Drug Submission (ANDS)
- PRAVASTATINJanuary 14, 2011 · NOC 12002 · Abbreviated New Drug Submission (ANDS)
- PANTOPRAZOLEDecember 29, 2010 · NOC 11961 · Abbreviated New Drug Submission (ANDS)
- VALACYCLOVIRNovember 18, 2010 · NOC 11876 · Abbreviated New Drug Submission (ANDS)
- PRAMIPEXOLENovember 18, 2010 · NOC 11878 · Abbreviated New Drug Submission (ANDS)
- ALENDRONATENovember 15, 2010 · NOC 11869 · Abbreviated New Drug Submission (ANDS)
- FLUCONAZOLEJune 21, 2010 · NOC 11543 · Abbreviated New Drug Submission (ANDS)
- ATENOLOLMay 25, 2010 · NOC 11406 · New Drug Submission (NDS)
- LETROZOLEApril 28, 2010 · NOC 11306 · Abbreviated New Drug Submission (ANDS)
- FLUCONAZOLEApril 22, 2010 · NOC 11276 · Abbreviated New Drug Submission (ANDS)
- CHOLESTYRAMINE (LIGHT - LEMON-LIME FLAVOUR); CHOLESTYRAMINE (REGULAR); CHOLESTYRAMINE (LIGHT - ORANGE FLAVOUR)April 20, 2010 · NOC 11260 · New Drug Submission (NDS)
- ISMNApril 20, 2010 · NOC 11262 · Abbreviated New Drug Submission (ANDS)
- CAPTOPRILApril 20, 2010 · NOC 11264 · Abbreviated New Drug Submission (ANDS)
- METOPROLOL-LApril 20, 2010 · NOC 11267 · New Drug Submission (NDS)
- BICALUTAMIDEApril 9, 2010 · NOC 11238 · Abbreviated New Drug Submission (ANDS)
- AMIODARONEApril 9, 2010 · NOC 11240 · Abbreviated New Drug Submission (ANDS)
- RANITIDINEApril 8, 2010 · NOC 11228 · Abbreviated New Drug Submission (ANDS)
- ENALAPRILApril 1, 2010 · NOC 11215 · Abbreviated New Drug Submission (ANDS)
- LEVOFLOXACINApril 1, 2010 · NOC 11216 · Abbreviated New Drug Submission (ANDS)
- LISINOPRILApril 1, 2010 · NOC 11217 · Abbreviated New Drug Submission (ANDS)
- METFORMINApril 1, 2010 · NOC 11218 · New Drug Submission (NDS)
- VERAPAMIL SRApril 1, 2010 · NOC 11219 · Abbreviated New Drug Submission (ANDS)
- CYCLOBENZAPRINEApril 1, 2010 · NOC 11220 · New Drug Submission (NDS)
- SOTALOLApril 1, 2010 · NOC 11221 · Abbreviated New Drug Submission (ANDS)
- BISOPROLOLApril 1, 2010 · NOC 11223 · Abbreviated New Drug Submission (ANDS)
- RIVASTIGMINEApril 1, 2010 · NOC 11224 · Abbreviated New Drug Submission (ANDS)
- MELOXICAMApril 1, 2010 · NOC 11225 · Abbreviated New Drug Submission (ANDS)
- DICLOFENACMarch 31, 2010 · NOC 11202 · Abbreviated New Drug Submission (ANDS)